Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Agios Pharmaceuticals (AGIO) Revenue (2016 - 2025)

Historic Revenue for Agios Pharmaceuticals (AGIO) over the last 13 years, with Q3 2025 value amounting to $12.9 million.

  • Agios Pharmaceuticals' Revenue rose 4368.59% to $12.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $44.8 million, marking a year-over-year increase of 3626.3%. This contributed to the annual value of $36.5 million for FY2024, which is 3606.98% up from last year.
  • According to the latest figures from Q3 2025, Agios Pharmaceuticals' Revenue is $12.9 million, which was up 4368.59% from $12.5 million recorded in Q2 2025.
  • Over the past 5 years, Agios Pharmaceuticals' Revenue peaked at $12.9 million during Q3 2025, and registered a low of $832000.0 during Q1 2022.
  • Over the past 4 years, Agios Pharmaceuticals' median Revenue value was $7.4 million (recorded in 2023), while the average stood at $7.4 million.
  • Its Revenue has fluctuated over the past 5 years, first soared by 57415.87% in 2023, then soared by 655.76% in 2025.
  • Over the past 4 years, Agios Pharmaceuticals' Revenue (Quarter) stood at $4.3 million in 2022, then skyrocketed by 64.8% to $7.1 million in 2023, then surged by 51.06% to $10.7 million in 2024, then rose by 20.04% to $12.9 million in 2025.
  • Its last three reported values are $12.9 million in Q3 2025, $12.5 million for Q2 2025, and $8.7 million during Q1 2025.